![](/img/cover-not-exists.png)
TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy
Matsusaka, S., Zhang, W., Cao, S., Hanna, D. L., Sunakawa, Y., Sebio, A., Ueno, M., Yang, D., Ning, Y., Parekh, A., Okazaki, S., Berger, M. D., Ichikawa, W., Mizunuma, N., Lenz, H.-J.Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-15-0751
Date:
March, 2016
File:
PDF, 583 KB
english, 2016